Study of Vitamin D in Untreated Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Metastatic Colorectal Cancer
Related studies linked through entity extraction aliases.
Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
- Status
- TERMINATED
- Phase
- PHASE2
A Phase II Study of Gemcitabine and Capecitabine for Treatment Resistant, Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Retrospective Review of Liver Resection Rate in Metastatic Colorectal Cancer Patients Following Downsizing Treatment With Chemotherapy Plus Cetuximab in Normal UK National Health Service Clinical Practice
- Status
- COMPLETED
- Phase
- N/A
First-line FOLFOXIRI Plus Bevacizumab in BRAF Mutant Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- N/A
Comparison of Survival Benefit of Panitumumab With Supportive Care to Best Supportive Care Alone in Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
PERfusion CT in the FOXFIRE Trial to Study Blood Flow to Liver Metastases
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
A Study Evaluating the Efficacy and Safety of MEGF0444A Dosed to Progression in Combination With Bevacizumab and mFOLFOX-6 in Participants With Previously Untreated Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Irinotecan, Cetuximab and Everolimus to Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Recombinant Anti-tumor and Anti-virus Protein for Injection in Treatment of Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of VEGF Polymorphism as Predictive Factor in Metastatic Colorectal Cancer Treated With Folfiri Plus Bevacizumab
- Status
- UNKNOWN
- Phase
- N/A
Efficacy and Safety of the Prophylactic Use of Doxycycline +/- Vitamin K Cream
- Status
- COMPLETED
- Phase
- PHASE2
FOLFOXIRI With or Without Panitumumab in Metastatic Colorectal Cancer (VOLFI)
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy of FOLFOX+Bevacizumab in Combination With Irinotecan in the Treatment of Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Hepatic Arterial Infusion With Intravenous Irinotecan, 5FU and Leucovorin With or Without Panitumumab, in Patients With Wild Type RAS Who Have Resected Hepatic Metastases From Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Trial of Capecitabine (Xeloda), Oxaliplatin and Irinotecan in Combination With Bevacizumab in 1st Line Treatment of Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- N/A
IXO+A in mCRC With Liver-only Metastases
- Status
- WITHDRAWN
- Phase
- PHASE2
Trial of FOLF(HA)Iri Versus FOLFIRI in mCRC
- Status
- UNKNOWN
- Phase
- PHASE3
Study Assessing Potential Predictive Tumor Markers in Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Simvastatin + Cetuximab/Irinotecan in K-ras Mutant Colorectal Cancer (CRC)
- Status
- COMPLETED
- Phase
- PHASE2